Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Spotlight on antiinfective vaccine research in the U.S.

Oct. 18, 1996

New immunosuppressants disclosed by Merck & Co.

Oct. 18, 1996

Potential Chlamydia vaccine effective in preclinical studies

Oct. 18, 1996

University of Texas discloses OMPs for immunotherapy

Oct. 18, 1996

Lyme disease vaccine claimed by University of Minnesota

Oct. 18, 1996

Magainin discloses LAP for microbial infections

Oct. 18, 1996

New combination meningitis/hepatitis vaccine approved

Oct. 11, 1996

Fujisawa pursues new indications for tacrolimus

Oct. 11, 1996

Successful reversal of acute kidney graft rejection with Thymoglobulin

Oct. 11, 1996

BioTransplant's transplant technologies covered by four new patents

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...